Bernd R. Seizinger Aprea Therapeutics, Inc. (APRE) insider trading activity

Bernd R. Seizinger is Director of Aprea Therapeutics, Inc.. Currently has a direct ownership of 44,730 shares of APRE, which is worth approximately $140,452. The most recent transaction as insider was on Oct 11, 2024, when has been sold 10,000 shares (Common Stock) at a price of $2.68 per share, resulting in proceeds of $26,800. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 44.7K

28.79% 3M change

66.75% 12M change

Total Value Held $140,452

Bernd R. Seizinger Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 11 2024	BUY Open market or private purchase	$26,800 $2.68 p/Share	10,000 Added 18.27%	44,730 Common Stock
Jun 20 2024	BUY Grant, award, or other acquisition	-	1,045 Added 2.92%	34,730 Common Stock
Mar 13 2024	BUY Open market or private purchase	$50,009 $7.29 p/Share	6,860 Added 16.92%	33,685 Common Stock
Aug 23 2023	BUY Grant, award, or other acquisition	-	500 Added 1.83%	26,825 Common Stock
Jun 07 2023	BUY Open market or private purchase	$22,186 $3.68 p/Share	6,029 Added 18.63%	26,325 Common Stock
Jun 06 2023	BUY Open market or private purchase	$14,766 $3.63 p/Share	4,068 Added 16.7%	20,296 Common Stock
Jul 28 2022	BUY Grant, award, or other acquisition	-	5,995 Added 1.81%	324,575 Common Stock
May 18 2022	BUY Open market or private purchase	$35,500 $0.71 p/Share	50,000 Added 13.57%	318,580 Common Stock
Jun 30 2021	BUY Grant, award, or other acquisition	-	4,610 Added 1.69%	268,580 Common Stock

Also insider at

APTO

Aptose Biosciences Inc. Healthcare

BRS